Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Tong, Guoxin ^a,b   Wang, Ningfu ^b   Leng, Jianhang ^b   Tong, Xiaoshan ^b   Shen, Yun ^b   Yang, Jianmin ^b   Ye, Xianhua ^b   Zhou, Liang ^b   Zhou, Yujie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Angiography; Coronary artery disease; Genetics; Gensini score; Single nucleotide polymorphism; Sullivan Extent score

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ADIPOQ PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CHINA; COMPLICATION; DIABETIC ANGIOPATHY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84876086742     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-67     Document Type: Article

References (45)

1. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). 1996. Biochem Biophys Res Commun 2012, 425(3):556-559. 10.1016/j.bbrc.2012.08.023, 22925673.
2. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circulation J: official journal of the Japanese Circulation Society 2004, 68(11):975-981.
3. Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroentero: WJG 2011, 17(23):2801-2811.
4. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302(2):179-188. 10.1001/jama.2009.976, 19584347.
5. Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Cruz-Bautista I, Arellano-Campos O, Navarrete-Lopez M, Aguilar-Salinas CA. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol 2010, 9:26. 10.1186/1475-2840-9-26, 2902434, 20573249.
6. Boer-Martins L, Figueiredo VN, Demacq C, Martins LC, Consolin-Colombo F, Figueiredo MJ, Cannavan FP, Moreno H. Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol 2011, 10:24. 10.1186/1475-2840-10-24, 3072316, 21426540.
7. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, Okada T, Nakagawa Y, Tamba S, Kuroda Y. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circulation J: official journal of the Japanese Circulation Society 2008, 72(1):23-28.
8. Kollias A, Tsiotra PC, Ikonomidis I, Maratou E, Mitrou P, Kyriazi E, Boutati E, Lekakis J, Economopoulos T, Kremastinos DT. Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovasc Diabetol 2011, 10:14. 10.1186/1475-2840-10-14, 3042923, 21284833.
9. Breitfeld J, Stumvoll M, Kovacs P. Genetics of adiponectin. Biochimie 2012, 94(10):2157-2163. 10.1016/j.biochi.2012.03.004, 22449616.
10. Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, Kawamoto T, Matsumoto S, Nagaretani H, Kumada M. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 2004, 43(7):1195-1200. 10.1016/j.jacc.2003.10.049, 15063429.
11. Jung CH, Rhee EJ, Kim SY, Shin HS, Kim BJ, Sung KC, Kim BS, Lee WY, Kang JH, Oh KW. Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases. Endocr J 2006, 53(5):671-677. 10.1507/endocrj.K06-020, 16926524.
12. Jang Y, Chae JS, Koh SJ, Hyun YJ, Kim JY, Jeong YJ, Park S, Ahn CM, Lee JH. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin Chim Acta 2008, 391(1-2):85-90.
13. Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006, 55(2):375-384. 10.2337/diabetes.55.02.06.db05-0747, 16443770.
14. Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesaniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009, 17(4):737-744.
15. Hivert MF, Manning AK, McAteer JB, Florez JC, Dupuis J, Fox CS, O'Donnell CJ, Cupples LA, Meigs JB. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008, 57(12):3353-3359. 10.2337/db08-0700, 2584143, 18776141.
16. Hoefle G, Muendlein A, Saely CH, Risch L, Rein P, Koch L, Schmid F, Aczel S, Marte T, Langer P. The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men. Thromb Haemost 2007, 97(3):451-457.
17. Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L, Vigna C, Fanelli R, Di Mario U, Doria A. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004, 27(8):2015-2020. 10.2337/diacare.27.8.2015, 15277433.
18. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51(3):606. 10.1016/S0002-9149(83)80105-2, 6823874.
19. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990, 119(6):1262-1267. 10.1016/S0002-8703(05)80173-5, 1972310.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
21. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74(4):765-769. 10.1086/383251, 1181954, 14997420.
22. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70(2):425-434. 10.1086/338688, 384917, 11791212.
23. Grabe N. AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2002, 2(1):S1-15.
24. Barth N, Langmann T, Scholmerich J, Schmitz G, Schaffler A. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways. Diab tologia 2002, 45(10):1425-1433.
25. Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE, Shao J. C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 2005, 54(6):1744-1754. 10.2337/diabetes.54.6.1744, 15919796.
26. Laumen H, Saningong AD, Heid IM, Hess J, Herder C, Claussnitzer M, Baumert J, Lamina C, Rathmann W, Sedlmeier EM. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009, 58(4):984-991. 10.2337/db07-1646, 2661577, 19074982.
27. Zhang D, Ma J, Brismar K, Efendic S, Gu HF. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study. J Diabetes Complications 2009, 23(4):265-272. 10.1016/j.jdiacomp.2008.05.004, 18599322.
28. Ding M, Xie Y, Wagner RJ, Jin Y, Carrao AC, Liu LS, Guzman AK, Powell RJ, Hwa J, Rzucidlo EM. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol 2011, 31(6):1403-1410. 10.1161/ATVBAHA.110.216804, 3100723, 21454807.
29. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, Pedersen AA, Kalthoff C, Tullin S, Sams A. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010, 285(9):6153-6160. 10.1074/jbc.M109.088708, 2825410, 20028977.
30. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002, 277(40):37487-37491. 10.1074/jbc.M206083200, 12138120.
31. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003, 278(4):2461-2468. 10.1074/jbc.M209033200, 12431986.
32. Zhang H, Mo X, Hao Y, Huang J, Lu X, Cao J, Gu D. Adiponectin levels and risk of coronary heart disease: a meta-analysis of prospective studies. Am J Med Sci 2012, in press.
33. Patel S, Flyvbjerg A, Kozakova M, Frystyk J, Ibrahim IM, Petrie JR, Avery PJ, Ferrannini E, Walker M. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J 2008, 29(3):386-393. 10.1093/eurheartj/ehm526, 18084018.
34. Wilson SR, Sabatine MS, Wiviott SD, Ray KK, De Lemos JA, Zhou S, Rifai N, Cannon CP, Morrow DA. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J 2011, 161(6):1147-1155. e1141, 10.1016/j.ahj.2011.02.014, 21641362.
35. Li Q, Lu Y, Sun L, Yan J, Yan X, Fang L, Li M, Fan Z. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metabolism 2012, 61(12):1803-1808. 10.1016/j.metabol.2012.06.001, 22789446.
36. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, Legge DG, Quan H, Zhao MM, Ning N. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diab tologia 2011, 54(9):2303-2314.
37. Gong M, Long J, Liu Q, Deng HC. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010, 325(1-2):78-83.
38. Zhang H, Mo X, Hao Y, Gu D. Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med Genet 2012, 13:40. 3413575, 22639977.
39. Zhong C, Zhen D, Qi Q, Genshan M. A lack of association between adiponectin polymorphisms and coronary artery disease in a Chinese population. Genet Mol Biol 2010, 33(3):428-433. 10.1590/S1415-47572010005000064, 3036118, 21637408.
40. Chen G, Qin Q, Li Y, Ren B, Lu YR, Kou L, Yang N, Feng JP, Zhao BR. [Association between plasma adiponectin and small, dense low density lipoprotein in patients with coronary artery disease]. Zhonghua xin xue guan bing za zhi 2012, 40(9):752-756.
41. Altshuler D, Daly M. Guilt beyond a reasonable doubt. Nat Genet 2007, 39(7):813-815. 10.1038/ng0707-813, 17597768.
42. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449(7164):851-861. 10.1038/nature06258, 2689609, 17943122.
43. Lacquemant C, Froguel P, Lobbens S, Izzo P, Dina C, Ruiz J. The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 2004, 21(7):776-781. 10.1111/j.1464-5491.2004.01224.x, 15209773.
44. Gui MH, Li X, Jiang SF, Gao J, Lu DR, Gao X. Association of the adiponectin gene rs1501299 G>T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population. Diabetes Res Clin Pract 2012, 97(3):499-504. 10.1016/j.diabres.2012.05.011, 22748670.
45. Siitonen N, Pulkkinen L, Lindstrom J, Kolehmainen M, Schwab U, Eriksson JG, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M. Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Cardiovasc Diabetol 2011, 10:83. 10.1186/1475-2840-10-83, 3196906, 21943112.